Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab

Abstract We report the case of a Jehovah's Witness adolescent patient with immune‐mediated thrombotic thrombocytopenic purpura after SARS‐Cov2 infection successfully treated without therapeutic plasma exchange (TPE) using caplacizumab, corticosteroids, rituximab, and extracorporeal immunoadsorption...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Teresa Marta Cardesa‐Salzmann, Bernhard Stephan, Arne Simon, Rhoikos Furtwängler, Dominik Schöndorf, Sabine Heine, Eyad Torfah, Margaux Lux, Sonja Meyer, Norbert Graf
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-05-01
Colecção:	Clinical Case Reports
Assuntos:	caplacizumab immune‐mediated TTP – SARS‐Cov2 immunoadsorption Jehovah's Witness therapy without therapeutic plasma exchange
Acesso em linha:	https://doi.org/10.1002/ccr3.5902
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!